Ibrance
NDC 0069-0284, palbociclib, tablet, film coated, from Pfizer Laboratories Div Pfizer Inc.
- Product NDC
- 0069-0284
- Status
- Listed
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA212436
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0284 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PALBOCICLIB75 mg/1
Pharmacologic classes
Cytochrome P450 3A Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0069-0284-03 | 00069028403 | 3 DOSE PACK in 1 CARTON (0069-0284-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (0069-0284-07) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fecbdd7d-b729-41b5-9872-231b8fe104ce
Use it
Look up 0069-0284 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0069-0284 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0069-0284. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.